Difference between revisions of "Pharm Tech Minutes 2015.03.11"
Jump to navigation
Jump to search
(2 intermediate revisions by the same user not shown) | |||
Line 18: | Line 18: | ||
** [ftp://ftp.ihe.net/Pharmacy/TF_Maintenance-2015/CPs/Drafts/CP-PHARM-mtp-pre-1.doc Draft here] | ** [ftp://ftp.ihe.net/Pharmacy/TF_Maintenance-2015/CPs/Drafts/CP-PHARM-mtp-pre-1.doc Draft here] | ||
** Goal: distinguish between reference to PRE and reference to MTP (same content) | ** Goal: distinguish between reference to PRE and reference to MTP (same content) | ||
− | ** Decision: | + | ** Decision: to be discussed p2p Jürgen - Stéphane next week |
<p> </p> | <p> </p> | ||
Line 25: | Line 25: | ||
** Goal: when included in a PML, preserve the fact that several PREs or MTPs are coming from the same CDA document | ** Goal: when included in a PML, preserve the fact that several PREs or MTPs are coming from the same CDA document | ||
** Useful also for DIS and PADV? | ** Useful also for DIS and PADV? | ||
− | ** Decision: | + | ** Decision: Jürgen working on a CP |
− | |||
=== Review of CMPD Profile document === | === Review of CMPD Profile document === | ||
* [ftp://ftp.ihe.net/Pharmacy/yr6_2014-2015/Technical_Committee/Profiles/MedicationTreatmentPlan,%20MTP/IHE_Pharmacy_Suppl_CMPD_Rev1.5_TI_2015-03-10.docx Draft here] | * [ftp://ftp.ihe.net/Pharmacy/yr6_2014-2015/Technical_Committee/Profiles/MedicationTreatmentPlan,%20MTP/IHE_Pharmacy_Suppl_CMPD_Rev1.5_TI_2015-03-10.docx Draft here] | ||
* Next steps: | * Next steps: | ||
− | ** | + | ** Medication Treatment Placer is not mandatory - supported actors are described in concrete projects --> OK |
+ | ** Workflow: leave as they are, add a new section for explaining how the plan layer relates to existing workflow |
Latest revision as of 09:46, 11 March 2015
Review of MTP Profile document
- Glossary & definitions (pages 8, 10, 25)
- Decision:
- One MTP Item per MTP Document
- MTP Definition = THE patient's plan
- Open issue: linking MTP Items together to reflect some relationships between them
- Decision:
- Reported medications (page 16)
- Decision: agreed on modified wording (MTP Item when HP endorses the medication) in order not to have conflict/duplicate with further Medication Statement
- Next steps
- Decision: Update according to discussed points above
Review of CPs
- CP mtp-pre-1: link PRE --> MTP & type of referenced content
- Draft here
- Goal: distinguish between reference to PRE and reference to MTP (same content)
- Decision: to be discussed p2p Jürgen - Stéphane next week
- CP mtp-pre-2: Reference to original CDA document (when in PML)
- Draft here
- Goal: when included in a PML, preserve the fact that several PREs or MTPs are coming from the same CDA document
- Useful also for DIS and PADV?
- Decision: Jürgen working on a CP
Review of CMPD Profile document
- Draft here
- Next steps:
- Medication Treatment Placer is not mandatory - supported actors are described in concrete projects --> OK
- Workflow: leave as they are, add a new section for explaining how the plan layer relates to existing workflow